letrozole has been researched along with Abnormalities, Congenital in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Letrozole is a potent, nonsteroidal, aromatase inhibitor, originally used for postmenopausal breast cancer therapy, at present its only registered indication." | 5.37 | Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. ( Casper, RF; Mitwally, MF, 2011) |
| "Letrozole is a potent, nonsteroidal, aromatase inhibitor, originally used for postmenopausal breast cancer therapy, at present its only registered indication." | 1.37 | Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. ( Casper, RF; Mitwally, MF, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yun, J | 1 |
| Choi, YS | 1 |
| Lee, I | 1 |
| Won, YB | 1 |
| Lee, JH | 1 |
| Seo, SK | 1 |
| Cho, S | 1 |
| Lee, BS | 1 |
| Yun, BH | 1 |
| Sharma, S | 1 |
| Ghosh, S | 1 |
| Singh, S | 1 |
| Chakravarty, A | 1 |
| Ganesh, A | 1 |
| Rajani, S | 1 |
| Chakravarty, BN | 1 |
| Casper, RF | 2 |
| Mitwally, MF | 1 |
| Tulandi, T | 1 |
| Martin, J | 1 |
| Al-Fadhli, R | 1 |
| Kabli, N | 1 |
| Forman, R | 1 |
| Hitkari, J | 1 |
| Librach, C | 1 |
| Greenblatt, E | 1 |
4 other studies available for letrozole and Abnormalities, Congenital
| Article | Year |
|---|---|
Comparison of congenital malformations among babies born after administration of letrozole or clomiphene citrate for infertility treatment in a Korean cohort.
Topics: Adult; Aromatase Inhibitors; Asian People; Clomiphene; Cohort Studies; Congenital Abnormalities; Fem | 2018 |
Congenital malformations among babies born following letrozole or clomiphene for infertility treatment.
Topics: Birth Weight; Child; Child, Preschool; Clomiphene; Congenital Abnormalities; Female; Fertility Agent | 2014 |
Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome.
Topics: Anovulation; Aromatase Inhibitors; Clomiphene; Congenital Abnormalities; Female; Fertility Agents, F | 2011 |
Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate.
Topics: Adult; Aromatase Inhibitors; Canada; Clomiphene; Comorbidity; Congenital Abnormalities; Female; Fert | 2006 |